Jordi Guardiola

ORCID: 0000-0002-0464-241X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Colorectal Cancer Screening and Detection
  • Helicobacter pylori-related gastroenterology studies
  • Eosinophilic Esophagitis
  • Gastrointestinal disorders and treatments
  • Gastrointestinal Bleeding Diagnosis and Treatment
  • Immunodeficiency and Autoimmune Disorders
  • Diverticular Disease and Complications
  • Genetic factors in colorectal cancer
  • Mycobacterium research and diagnosis
  • Biosimilars and Bioanalytical Methods
  • Autoimmune and Inflammatory Disorders
  • Gut microbiota and health
  • Liver Disease and Transplantation
  • Gastric Cancer Management and Outcomes
  • Clostridium difficile and Clostridium perfringens research
  • Esophageal and GI Pathology
  • Diagnosis and treatment of tuberculosis
  • Gastrointestinal motility and disorders
  • Liver Diseases and Immunity
  • Pregnancy and Medication Impact
  • Gastroesophageal reflux and treatments
  • Colorectal Cancer Surgical Treatments
  • Monoclonal and Polyclonal Antibodies Research

Bellvitge University Hospital
2016-2025

Universitat de Barcelona
2012-2025

Institut d'Investigació Biomédica de Bellvitge
2015-2024

Merrion Fertility Clinic
2024

Ajuntament de L’Hospitalet
2021-2024

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública
2017-2020

Hull York Medical School
2020

Bassetlaw Hospital
2020

University of Medicine 2 Yangon
2020

University of Copenhagen
2020

Silvio Danese Séverine Vermeire Geert R. D’Haens Julián Panés Axel Dignaß and 95 more Fernando Magro Maciej Nazar Manuela Le Bars Marjolein Lahaye Lioudmila Ni Ivana Bravatà F. Lavie Marco Daperno Milan Lukáš Alessandro Armuzzi Mark Löwenberg Daniel R. Gaya Laurent Peyrin–Biroulet Rodolfo Rocca Susana Lopes Flavio Caprioli Sandro Ardizzone Ana Echarri Paolo Gionchetti Xavier Roblin Ursula Seidler David Andersson Kamal Patel Pierre Desreumaux Simone Saibeni Gustav From Miroslav Fedurco Miloš Greguš Yoram Bouhnik Andreas Luegering R. Cosintino Ivan Bunganič Jaime A. Ramos Mariam Aguas Peris Olivier Dewit Mariabeatrice Principi Emma Wesley Paula Lago Stéphane Nancey María Dolores Martín‐Arranz P. Hindryckx Ambrogio Orlando Andrea Geccherle Maria Laura Annunziata Bu Hayee Jozef Baláž Francisco Portela Cyrielle Gilletta Torsten Kucharzik Miguel Mínguez Javier P. Gisbert Ana Gutiérrez Édouard Louis Marco Marino Gareth M. B. Parkes Fraser Cummings Bindia Jharap Jens Kjeldsen L Correia Paula Ministro Matthias Ebert Erik Hertervig Dirk Staessen Joris Dutré A Colard Graham Morrison Henning Glerup Jens Frederik Dahlerup Frank H.J. Wolfhagen M Bátovský Martin Molnar Barbora Kadleckova Paulo Caldeira David Laharie Xavier Hébuterne Bruno Bonaz Matthieu Allez Andreas Fischer Joaquín Ernesto Hinojosa Del Val Míriam Mañosa Círia José Manuel Herrera Justiniano Charlotte Söderman Rajiv Chandy Craig Mowat Peter M. Irving Jan Fallingborg Jan Matouš Tomáš Douda Romain Altwegg J M Benítez M Arroyo Jordi Guardiola Daniel Ginard Vicenc Pieter Dewint Sven Almér

10.1016/s2468-1253(21)00474-x article EN ˜The œLancet. Gastroenterology & hepatology 2022-02-02

Spontaneous bacterial empyema (SBEM) is an infection of a preexisting hydrothorax in cirrhotic patients and has seldom been reported. To determine its incidence primary characteristics, all with pleural effusion underwent thoracentesis at our hospital either on admission or when was suspected. Pleural fluid (PF) study included biochemical analysis, polymorphonuclear (PMN) leukocyte count, culture by two methods: conventional modified (inoculation 10 mL PF into blood bottle the bedside). SBEM...

10.1002/hep.510230410 article EN Hepatology 1996-04-01

Fecal calprotectin (FC), as determined by the enzyme-linked immunoassay (ELISA) test, has been proposed a promising biomarker of endoscopic activity in Crohn's disease (CD). However data on its accuracy predicting remission according to location and postoperative recurrence (POR) is scarce. Our objective was evaluate ability FC new quantitative point-of-care test (FC-QPOCT) predict POR CD patients.FC simultaneously an (FC-ELISA) FC-QPOCT patients undergoing colonoscopy. Clinical assessed...

10.1016/j.crohns.2013.05.005 article EN Journal of Crohn s and Colitis 2013-07-01

DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer (CRC) and precursor lesions have been extensively studied. Different panels reported attempting to improve current protocols in clinical practice, although no definite established. In the present study, we examined patient biopsies starting from a comprehensive analysis differences between paired normal tumor samples known cancer-related genes aiming select best performing candidates informative CRC stool samples. Five...

10.1158/1940-6207.capr-12-0501 article EN Cancer Prevention Research 2013-05-22

Fecal calprotectin (FC) determined by the enzyme-linked immunosorbent assay (ELISA) test has been proposed as a promising biomarker of endoscopic activity in ulcerative colitis (UC). However, data on its accuracy predicting is scarce. Besides, FC quantitative-point-of-care (FC-QPOCT) that provides rapid and individual results could optimize use clinical practice. The aims our study were to evaluate ability predict according Mayo score patients with UC when FC-QPOCT compare it ELISA...

10.1097/mib.0b013e3182802b6e article EN Inflammatory Bowel Diseases 2013-03-07
María José Casanova María Chaparro Valle García–Sánchez Óscar Nantes E Leo and 78 more M Rojas-Feria Aranzazu Jauregui-Amezaga Santiago García‐López José María Huguet Federico Argüelles‐Arias Marta Aicart Ignacio Marín‐Jiménez María Gómez–García Fernándo Muñoz María Esteve Luís Bujanda Xavier Cortés Joan Toscá J R Pineda Míriam Mañosa J Llaó Jordi Guardiola Isabel Pérez‐Martínez Clara Muñoz Yago González‐Lama Joaquín Hinojosa J.M. Vázquez Pilar Martínez-Montiel G E Rodríguez Ramón Pajares Mariana Fe García-Sepulcre Álvaro Hernández-Martínez J L Pérez-Calle Belén Beltrán David Busquets Laura Ramos Fernando Bermejo Jesús Barrio Manuel Barreiro–de Acosta O Roncedo Xavier Calvet Daniel Hervías Fernando Gomollón Mercedes Domínguez-Antonaya G Alcaín Beatriz Sicilia Carmelo Dueñas Castell Ana Gutiérrez Rufo Humberto Lorente-Poyatos M.Á. Domínguez Sam Khorrami Carlos Taxonera Aurelio Rodríguez Ángel Ponferrada Manuel Van Domselaar María Luisa Arias-Rivera Olga Merino Esmeralda Gracián-Castro José Miguel Marrero María Dolores Martín‐Arranz Belén Botella Luis Fernández‐Salazar David Monfort Verónica Opio Antonio García‐Herola M Menacho Ramírez-de P la Piscina Daniel Ceballos Pedro Almela Mercè Navarro‐Llavat Virginia Robles ANAHI VEGA-LOPEZ Irene Moraleja M T Novella Carlos Castańo-Milla Alba Sánchez‐Torres J M Benítez Cristina Rodríguez Luisa de Castro Elena Azaola Eugeni Domènech E. García‐Planella Javier P. Gisbert

The aims of this study were to assess the risk relapse after discontinuation anti-tumor necrosis factor (anti-TNF) drugs in patients with inflammatory bowel disease (IBD), identify factors associated relapse, and evaluate overcome retreatment same anti-TNF those who relapsed.This was a retrospective, observational, multicenter study. IBD had been treated anti-TNFs whom these discontinued clinical remission achieved included.A total 1,055 included. incidence rate 19% 17% per patient-year...

10.1038/ajg.2016.569 article EN The American Journal of Gastroenterology 2016-12-13

The development programm UNIFI has shown promising results of ustekinumab in ulcerative colitis [UC] treatment which should be confirmed clinical practice. We aimed to evaluate the durability, effectiveness, and safety UC real life.Patients included prospectively maintained ENEIDA registry, who received at least one intravenous dose due active [Partial Mayo Score [PMS]>2], were included. Clinical activity effectiveness defined based on PMS. Short-term response was assessed Week 16.A total 95...

10.1093/ecco-jcc/jjab070 article EN Journal of Crohn s and Colitis 2021-04-12

Transcatheter arterial chemoembolization (TACE) has been used as a palliative treatment for patients with unresectable hepatocellular carcinoma (HCC), but its prognostic usefulness not previously clarified.The authors reviewed all treated at their institution TACE HCC in order to analyze factors and determine which might benefit from this treatment. One hundred forty-three were retrospectively studied. Pretreatment, treatment, follow-up variables possible significance analyzed. A stepwise...

10.1002/(sici)1097-0142(20000101)88:1<50::aid-cncr8>3.0.co;2-i article EN Cancer 2000-01-01

RJ 2.2.5 is a human B cell line that has lost the capacity to express MHC class II genes. The II-positive phenotype restored in somatic hybrids between and mouse spleen cells. By karyotype molecular studies of an informative family we have now shown reexpression gene products, as well maintenance phenotype, correlates with presence chromosome 16. Thus, existence on this newly found locus, designated by us aIr-1, determines trans-acting activator function for expression, established. Possible...

10.1084/jem.164.1.369 article EN cc-by The Journal of Experimental Medicine 1986-07-01

Psoriasis induced by anti-tumor necrosis factor-α (TNF) therapy has been described as a paradoxical side effect.To determine the incidence, clinical characteristics, and management of psoriasis anti-TNF in large nationwide cohort inflammatory bowel disease patients.Patients with were identified from Spanish prospectively maintained Estudio Nacional en Enfermedad Inflamatoria Intestinal sobre Determinantes genéticos y Ambientales registry Grupo Español de Trabajo Croh Colitis Ulcerosa....

10.1097/mib.0000000000000757 article EN Inflammatory Bowel Diseases 2016-03-02

Postoperative recurrence of Crohn's disease [POR-CD] is almost certain if no prophylaxis administered. Evidence for optimal treatment lacking. Our aim was to compare the efficacy adalimumab [ADA] and azathioprine [AZA] in this setting. We performed a phase 3, 52-week, multicentre, randomised, superiority study [APPRECIA], which patients with ileocolonic resection were randomised either ADA 160-80-40 mg subcutaneously [SC] or AZA 2.5 mg/kg/day, both associated metronidazole. The primary...

10.1093/ecco-jcc/jjx051 article EN Journal of Crohn s and Colitis 2017-04-05

Background Histological remission has been proposed as a new treatment goal in patients with ulcerative colitis (UC) although no universal definition for microscopic activity exists. Aim We evaluated the accuracy of histological to predict clinical relapse UC both and endoscopic remission. Methods Asymptomatic (Mayo sub‐score 0 or 1) undergoing surveillance colonoscopy two referral hospitals were prospectively recruited. All colonic biopsies analyzed according Geboes’ score (GS) presence...

10.1177/2050640617752207 article EN United European Gastroenterology Journal 2018-01-09

Prediction models for colorectal cancer (CRC) detection in symptomatic patients, based on easily obtainable variables such as fecal haemoglobin concentration (f-Hb), age and sex, may simplify CRC diagnosis. We developed, then externally validated, a multivariable prediction model, the FAST Score, with data from five diagnostic test accuracy studies that evaluated quantitative immunochemical tests patients referred colonoscopy. The of Score derivation validation cohorts was compared...

10.1002/ijc.30639 article EN International Journal of Cancer 2017-02-10

Ulcerative colitis [UC] is a chronic inflammatory disease of the colon. Colonoscopy remains gold standard for evaluating activity, as clinical symptoms are not sufficiently accurate. The aim this study to identify new accurate non-invasive biomarkers based on whole-blood transcriptomics that can predict mucosal lesions and response treatment in UC patients.Whole-blood samples were collected total 152 patients at endoscopy. Blood RNA from 25 individuals 20 controls was analysed using...

10.1093/ecco-jcc/jjx091 article EN cc-by-nc Journal of Crohn s and Colitis 2017-07-06

There is controversy as to whether the risk of relevant infection in IBD related immunosuppressants or disease itself. The aims this study were evaluate: [1] life-long prevalence and types infections patients with immunosuppressive treatment, [2] relationship both patient comorbidity mortality.Observational multicentre retrospective that presented a infection. For each case, four periods exposure analysed: P1: pre-IBD diagnosis, P2: from diagnosis immunosuppressant initiation, P3: during...

10.1093/ecco-jcc/jjz013 article EN Journal of Crohn s and Colitis 2019-01-17

Eleven episodes of spontaneous bacterial empyema were identified in eight cirrhotic patients with ascites. Criteria for included positive pleural fluid culture or polymorphonuclear cell concentration greater than 500 cells/mm3, evidence effusion before an infectious episode and transudate characteristics during infection. In five cases, was culture-negative associated peritonitis. Ascitic two these cases culture-positive three. Blood cultures negative all cases. six (Escherichia coli four,...

10.1002/hep.1840110306 article EN Hepatology 1990-03-01

In this study, we aim to identify the genes responsible for colorectal cancer risk behind loci identified in genome-wide association studies (GWAS). These may be candidate targets developing new strategies prevention or therapy. We analyzed of genotypes 26 GWAS single nucleotide polymorphisms (SNPs) with expression within a 2 Mb region (cis-eQTLs). Affymetrix Human Genome U219 arrays were used assess gene two series samples, one healthy colonic mucosa (n = 47) and other normal adjacent colon...

10.1093/carcin/bgu092 article EN Carcinogenesis 2014-04-23
Coming Soon ...